Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:75391rdf:typepubmed:Citationlld:pubmed
pubmed-article:75391lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:75391lifeskim:mentionsumls-concept:C0149875lld:lifeskim
pubmed-article:75391lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:75391pubmed:issue8060lld:pubmed
pubmed-article:75391pubmed:dateCreated1978-4-17lld:pubmed
pubmed-article:75391pubmed:abstractTextThe prostaglandin-synthetase inhibitors, mefenamic acid and flufenamic acid, were compared with the analgesic, dextropropoxyphene/paracetamol, in the treatment of primary dysmenorrhoea in a double-blind crossover trial. Results were assessed in 30 patients who took each drug during menstruation for three consecutive cycles. The patients' assessment of each drug suggests that both mefenamic acid and flufenamic acid are more effective than the other analgesic for general relief of symptoms and for most of nine individual symptoms subjectively assessed by the patient. There was less absenteeism from work or school during mefenamic-acid treatment and fewer capsules of mefenamic acid were taken compared with the other two drugs. Patients took significantly fewer additional analgesics during mefenamic-acid therapy than during treatment with the other two drugs. 5 patients had possible side-effects--3 patients on mefenamic acid and 2 on dextropropoxyphene/paracetamol.lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:languageenglld:pubmed
pubmed-article:75391pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:citationSubsetAIMlld:pubmed
pubmed-article:75391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:75391pubmed:statusMEDLINElld:pubmed
pubmed-article:75391pubmed:monthFeblld:pubmed
pubmed-article:75391pubmed:issn0140-6736lld:pubmed
pubmed-article:75391pubmed:authorpubmed-author:AndersonA BABlld:pubmed
pubmed-article:75391pubmed:authorpubmed-author:TurnbullA CAClld:pubmed
pubmed-article:75391pubmed:authorpubmed-author:HaynesP JPJlld:pubmed
pubmed-article:75391pubmed:authorpubmed-author:FraserI SISlld:pubmed
pubmed-article:75391pubmed:issnTypePrintlld:pubmed
pubmed-article:75391pubmed:day18lld:pubmed
pubmed-article:75391pubmed:volume1lld:pubmed
pubmed-article:75391pubmed:ownerNLMlld:pubmed
pubmed-article:75391pubmed:authorsCompleteYlld:pubmed
pubmed-article:75391pubmed:pagination345-8lld:pubmed
pubmed-article:75391pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Hu...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Ad...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Dy...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Fe...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Dr...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Ad...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Ad...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-De...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Cl...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Do...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Ac...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Me...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Fl...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Dr...lld:pubmed
pubmed-article:75391pubmed:meshHeadingpubmed-meshheading:75391-Dr...lld:pubmed
pubmed-article:75391pubmed:year1978lld:pubmed
pubmed-article:75391pubmed:articleTitleTrial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea.lld:pubmed
pubmed-article:75391pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:75391pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:75391pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:75391pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:75391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:75391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:75391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:75391lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:75391lld:pubmed